POSTERS ESMO 2024

Cáncer de mama

Cáncer de mama temprano

Subtyping of residual disease (RD) following neoadjuvant chemotherapy (NACT) for triple negative breast cancer (TNBC): evolution and prognostic impact

Subtyping of residual disease (RD) following neoadjuvant chemotherapy (NACT) for triple negative breast cancer (TNBC): evolution and prognostic impact

Poster Bd #: 261P

Poster

Descargar poster

Autor
Isabel Echavarria Díaz-Guardamino

Hospital General Universitario Gregorio Marañón. Madrid

Compartir:

Una iniciativa científica de:

eco clover

Con el patrocinio de:

REGENERON